‘Cures’ bill, designed to speed drug approvals, could be too much of a good thing, dissenters say

For years, the FDA faced criticism that its one-size-fits-all approach to evaluating new drugs and devices was ill-conceived and failed to take into account a changing healthcare environment.  The agency has since made strides in shortening review times and accelerating the path for breakthrough treatments; however, a new bill designed to break down even more regulatory barriers has attracted a chorus of critics worried that it could go too far at the expense of patients.

Magic material: Graphene protects chemotherapy, but silver-lined catheters break it down

Catheters designed to deliver chemotherapy are often coated in silver to provide an antibacterial coating.  However, scientists at the Norwegian University of Science and Technology found that this silver actually breaks down chemotherapy drugs and can release a harmful gas, hydrogen fluoride in the process.  The researchers expect that graphene, which is a nonreactive substance, might be a better catheter coating.